Fernando Baquero, John F

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Grepafloxacin: microbiological properties
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Amoxycillin/clavulanate resistance as related to β-lactamase content in Escherichia coli strains from community-acquired urinary tract infections in Greece 
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Didier Guillemot, Claude Carbon  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
D.E. Low  Clinical Microbiology and Infection 
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
In vitro selective concentrations of cefepime and ceftazidime for AmpC β-lactamase hyperproducer Enterobacter cloacae variants  Maria-Cristina Negri,
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton 
Elements of design: the knowledge on which we build
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
André Bryskier  Clinical Microbiology and Infection 
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Jacques Sirot, Patrice Courvalin, Claude-James Soussy 
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
T.M. File  Clinical Microbiology and Infection 
Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France  Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
Community-acquired pneumonia: epidemiologic and clinical consideration
Grepafloxacin: pharmacokinetics and tissue penetration
Definition of the Clinical Antibacterial Spectrum of Activity
Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital  Nathalie Caroff, Didier Lepelletier,
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model  Alasdair P. MacGowan,
Sanford Chodosh  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Evaluation of the BBL CrystalTM MRSA ID System for Rapid Detection of Methicillin Resistance in Staphylococcus aureus  Sylvie Dutka-Malen, Murielle Charles,
Modification of prescribers’ behavior: the Icelandic approach
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Impact of antibiotic restrictions: the patient's perspective
Presentation transcript:

Epidemiology and mechanisms of resistance among respiratory tract pathogens  Fernando Baquero, John F. Barrett, Patrice Courvalin, Ian Morrissey, Laura Piddock, William J. Novick  Clinical Microbiology and Infection  Volume 4, Pages 2S19-2S26 (April 1998) DOI: 10.1111/j.1469-0691.1998.tb00691.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Worldwide frequency of isolation of penicillin-resistant pneumococci (MIC >0.12 mg/L: intermediate and high-level penicillin-resistant strains). Clinical Microbiology and Infection 1998 4, 2S19-2S26DOI: (10.1111/j.1469-0691.1998.tb00691.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Incidences of β-lactamase-positive H. influenzae strains in Europe. Clinical Microbiology and Infection 1998 4, 2S19-2S26DOI: (10.1111/j.1469-0691.1998.tb00691.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.